The Company continues to work towards reducing its net debt 1 to Adjusted EBITDA 1 ratio to below 4x. As a result of strong cash flows in Q1 FY2025, the Company made a voluntary prepayment of $20 ...
The Phase 2 TRANQUILITY trial, which evaluates quarterly and monthly subcutaneous dosing of pacibekitug in patients with elevated high-sensitivity C-reactive protein and chronic kidney disease, is ...
During the year ended 31 August 2024, Fidelity Special Values PLC reported a net asset value return of +24.1% and an ordinary share price total return of +24.3%. The Benchmark Index, the FTSE ...
Employers should take a holistic view of their 401(k) that considers plan design, employee profile and behaviors and communication programs so that the plan can be tailored to the profile of the ...
At the University of Connecticut’s Board of Trustees meeting on Wednesday, the provost’s review, the introduction of early decision and a review of Student Evaluation of Teaching (SET) surveys ...